| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0060024 | BP | rhythmic synaptic transmission | Any process involved in the generation of rhythmic, synchronous synaptic inputs in a neural circuit. |
PTEN |
GO:0060025 | BP | regulation of synaptic activity | Any process that modulates the frequency, rate or extent of synaptic activity, the controlled release of neurotransmitters into the synaptic cleft and their subsequent detection by a postsynaptic cell. |
MEF2C |
GO:0060026 | BP | convergent extension | The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis. |
LRP6, PTK7 |
GO:0060027 | BP | convergent extension involved in gastrulation | The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis usually resulting in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm. |
NPHP3, MKKS |
GO:0060028 | BP | convergent extension involved in axis elongation | The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis contributing to the lengthening of the axis of an organism. |
WNT5A, TRIM28 |
GO:0060029 | BP | convergent extension involved in organogenesis | The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis contribution to the shaping of an organ. |
WNT5A |
GO:0060032 | BP | notochord regression | The developmental process in which the stucture of the notochord is destroyed in an embryo. |
GLI2 |
GO:0060033 | BP | anatomical structure regression | The developmental process in which an anatomical stucture is destroyed as a part of its normal progression. |
LRP5, CD248 |
GO:0060037 | BP | pharyngeal system development | The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear. |
TBX1, PLXNA2, TGFBR1, ECE1, ACVR1, PTCH1 |
GO:0060038 | BP | cardiac muscle cell proliferation | The expansion of a cardiac muscle cell population by cell division. |
BMP10, PRKAR1A, NOTCH1, TGFB2, TGFBR3, FOXC1, SMAD1, TENM4, NDRG4 |
GO:0060039 | BP | pericardium development | The process whose specific outcome is the progression of the pericardium over time, from its formation to the mature structure. The pericardium is a double-walled sac that contains the heart and the roots of the aorta, vena cava and the pulmonary artery. |
BMP2, SMAD3, SMAD2, CCM2, HEG1 |
GO:0060041 | BP | retina development in camera-type eye | The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates. |
NPHP1, GRM6, PAX4, SKI, RRM1, SERPINF1, SOX9, LHX2, SOX8, GNB1, RPL24, BAX, MERTK, NECTIN1, NTRK2, JMJD6, PAPD4, ZNF513, MDM1, PFDN5, CHD7, LAMC3 |
GO:0060042 | BP | retina morphogenesis in camera-type eye | The process in which the anatomical structure of the retina is generated and organized. |
LRP5, PROX1, NECTIN3 |
GO:0060043 | BP | regulation of cardiac muscle cell proliferation | Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation. |
BMPR1A, TGFBR1 |
GO:0060044 | BP | negative regulation of cardiac muscle cell proliferation | Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle cell proliferation. |
RBP4, GJA1, TGFBR2, PTEN |
GO:0060045 | BP | positive regulation of cardiac muscle cell proliferation | Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation. |
BMP10, CDK1, FGF2, WNT2, FGFR1, CCNB1, FGFR2, FGF9, BMPR1A, NOTCH1, TGFBR3, MEF2C, ERBB4, MAPK14, ZFPM2, GATA6 |
GO:0060046 | BP | regulation of acrosome reaction | Any process that modulates the frequency, rate or extent of the acrosome reaction. |
SPINK1, B4GALT1 |
GO:0060047 | BP | heart contraction | The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body. |
GPX1, ACE, TNNI3, CDC42, ACTC1, RPS6KA2, SGCD, SGCZ |
GO:0060048 | BP | cardiac muscle contraction | Muscle contraction of cardiac muscle tissue. |
ATP1B1, TPM1, GAA, DMD, MYL4, TNNI3, PIK3CA, VEGFB, ATP1A2, MAP2K6, ACTC1, SRSF1, KCNH2, PPP1R13L, TTN, RYR2, SMAD5 |
GO:0060049 | BP | regulation of protein glycosylation | Any process that modulates the frequency, rate or extent of protein glycosylation. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins. |
MT3 |
GO:0060050 | BP | positive regulation of protein glycosylation | Any process that activates or increases the frequency, rate or extent of the glycosylation of one or more amino acid residues within a protein. Protein glycosylation is the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid, e.g. the addition of glycan chains to proteins. |
RAMP1, GOLGA2, CHP1 |
GO:0060052 | BP | neurofilament cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising neurofilaments and their associated proteins. |
NDEL1 |
GO:0060053 | CC | neurofilament cytoskeleton | Intermediate filament cytoskeletal structure that is made up of neurofilaments. Neurofilaments are specialized intermediate filaments found in neurons. |
NDEL1 |
GO:0060054 | BP | positive regulation of epithelial cell proliferation involved in wound healing | Any process that activates or increases the rate or extent of epithelial cell proliferation, contributing to the restoration of integrity to a damaged tissue following an injury. |
FZD7, B4GALT1 |
GO:0060055 | BP | angiogenesis involved in wound healing | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to a damaged tissue, following an injury. |
ITGB3, GPX1, ETS1, B4GALT1, PIK3CB, HPSE |
GO:0060056 | BP | mammary gland involution | The tissue remodeling that removes differentiated mammary epithelia during weaning. |
IGFBP5, ELF3, CAV1 |
GO:0060058 | BP | positive regulation of apoptotic process involved in mammary gland involution | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process of mammary epithelial cells during mammary gland involution. |
VDR, B4GALT1, BAX |
GO:0060059 | BP | embryonic retina morphogenesis in camera-type eye | The process in which the anatomical structure of the retina is generated and organized in a camera-type eye during the embryonic life stage. |
LRP6, RBP4, PROX1, HIPK2 |
GO:0060064 | BP | Spemann organizer formation at the anterior end of the primitive streak | Formation of the specialized region at the anterior end of the primitive streak of the embryo that acts as the main signaling center establishing the body plan. |
WNT3 |
GO:0060065 | BP | uterus development | The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure. |
RBP4, ESR1, HOXA10, WNT5A, CDKN1C, FOXL2, TGFB2, SMAD4 |
GO:0060066 | BP | oviduct development | The reproductive developmental process whose specific outcome is the progression of an oviduct over time, from its formation to the mature structure. An oviduct is a tube through which an ova passes from the ovary to the uterus, or from the ovary to the outside of the organism. |
CTNNB1 |
GO:0060067 | BP | cervix development | The reproductive developmental process whose specific outcome is the progression of the cervix over time, from its formation to the mature structure. |
WNT5A |
GO:0060068 | BP | vagina development | The reproductive developmental process whose specific outcome is the progression of the vagina over time, from its formation to the mature structure. |
RBP4, ESR1, WNT5A, TYRO3, BAX, MERTK |
GO:0060070 | BP | canonical Wnt signaling pathway | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
AXIN1, KDM6A, KLF4, SNAI2, TBL1X, FZD7, LRP5, LRP6, MYC, WNT2, SDC1, APC, CTNNB1, WNT5A, NR4A2, PSEN1, GSK3B, WNT3, PTEN, CDC42, UBE2B, SMAD3, NDP, SOX4, PTK7, DIXDC1, STK11, SFRP1, RYR2, MED12, WNT2B, PYGO2, TBL1XR1, FZD8, SOX17, CHD8, TCF7L1, TCF7L2, FZD4 |
GO:0060071 | BP | Wnt signaling pathway, planar cell polarity pathway | The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors including C-Jun N-terminal kinase (JNK) to modulate cytoskeletal elements and control cell polarity. |
PSMD11, PSMD12, PSMD3, FZD6, FZD7, GPC4, PSMD10, AP2A2, PFN1, UBC, PSMC3, PSMB1, PSMA1, PSMA2, PSMA3, PSMA4, PSMB8, PSMB9, PSMB4, PSMB5, PSMC2, PSMB10, WNT5A, PSMC4, PSMB3, PSMD7, AP2S1, CDC42, PSME3, RHOA, PSMC1, PSMC6, RPS27A, UBA52, RAC1, AP2B1, ROR1, TIAM1, PSMD2, PSME4, MED12, CTHRC1, AP2M1, PRICKLE1, SMURF2, PARD6A, CELSR3, FZD4, DAAM1, GPC6 |
GO:0060072 | MF | large conductance calcium-activated potassium channel activity | Enables the transmembrane transfer of potassium by a channel with a unit conductance of 100 to 220 picoSiemens that opens in response to stimulus by concerted actions of internal calcium ions and membrane potential. Large conductance calcium-activated potassium channels are less sensitive to calcium than are small or intermediate conductance calcium-activated potassium channels. Transport by a channel involves catalysis of facilitated diffusion of a solute (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel, without evidence for a carrier-mediated mechanism. |
KCNMA1 |
GO:0060073 | BP | micturition | The regulation of body fluids process in which parasympathetic nerves stimulate the bladder wall muscle to contract and expel urine from the body. |
ADRA1A, KCNMA1 |
GO:0060074 | BP | synapse maturation | The process that organizes a synapse so that it attains its fully functional state. Synaptic maturation plays a critical role in the establishment of effective synaptic connections in early development. |
PTEN |
GO:0060075 | BP | regulation of resting membrane potential | Any process that modulates the establishment or extent of a resting potential, the electrical charge across the plasma membrane, with the interior of the cell negative with respect to the exterior. The resting potential is the membrane potential of a cell that is not stimulated to be depolarized or hyperpolarized. |
KCNK1, PSEN1, KCNK6 |
GO:0060076 | CC | excitatory synapse | A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. |
SRPX2, SYT1, FGFR2, ITGA3, DLG4, NLGN4X, SYT11 |
GO:0060077 | CC | inhibitory synapse | A synapse in which an action potential in the presynaptic cell reduces the probability of an action potential occurring in the postsynaptic cell. |
SYT11, IGSF9B |
GO:0060078 | BP | regulation of postsynaptic membrane potential | Any process that modulates the potential difference across a post-synaptic membrane. |
PKD2, SCN9A, FGF14 |
GO:0060079 | BP | excitatory postsynaptic potential | A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. |
ADORA1, SNCA, CDK5, MEF2C, PPP3CA, GRIN2A, MAPK8IP2, RAB3GAP1, SLC29A1, GHRL |
GO:0060081 | BP | membrane hyperpolarization | The process in which membrane potential increases with respect to its steady-state potential, usually from negative potential to a more negative potential. For example, during the repolarization phase of an action potential the membrane potential often becomes more negative or hyperpolarized before returning to the steady-state resting potential. |
CFTR, CASP1, ADIPOQ |
GO:0060083 | BP | smooth muscle contraction involved in micturition | The process leading to shortening and/or development of tension in the urinary bladder smooth muscle tissue involved in the expulsion urine from the body. |
KCNMA1, TRPV1 |
GO:0060086 | BP | circadian temperature homeostasis | Any homeostatic process in which an organism modulates its internal body temperature at different values with a regularity of approximately 24 hours. |
NR1D1, TNFRSF11A |
GO:0060087 | BP | relaxation of vascular smooth muscle | A process in which the extent of vascular smooth muscle contraction is reduced. Vascular smooth muscle relaxation is mediated via a decrease in the phosphorylation state of myosin light chain. This can be achieved by removal of calcium from the cytoplasm to the sarcoplasmic reticulum lumen through the action of Ca2+ ATPases leading to a decrease myosin light chain kinase activity, and through calcium-independent pathways leading to a increase in myosin light chain phosphatase activity. |
ADORA2B, ADORA1, RGS2 |
GO:0060088 | BP | auditory receptor cell stereocilium organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of auditory hair cells. |
CLIC5 |
GO:0060090 | MF | binding, bridging | The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way. |
PDCD6, GAS6, TRADD |
GO:0060091 | CC | kinocilium | A nonmotile primary cilium that is found at the apical surface of auditory receptor cells. The kinocilium is surrounded by actin-based stereocilia. |
DCDC2 |
GO:0060100 | BP | positive regulation of phagocytosis, engulfment | Any process that activates or increases the frequency, rate or extent of the internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis. |
CD36, ITGA2, PPARG, F2RL1, ANO6 |
GO:0060112 | BP | generation of ovulation cycle rhythm | The process which controls the timing of the type of sexual cycle seen in female mammals. |
CHRNA7, KISS1, NPY5R |
GO:0060113 | BP | inner ear receptor cell differentiation | The process in which relatively unspecialized cells, acquire specialized structural and/or functional features of inner ear receptor cells. Inner ear receptor cells are mechanorecptors found in the inner ear responsible for transducing signals involved in balance and sensory perception of sound. |
BMP4 |
GO:0060117 | BP | auditory receptor cell development | The process whose specific outcome is the progression of an auditory receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
FGFR1 |
GO:0060119 | BP | inner ear receptor cell development | The process whose specific outcome is the progression of an inner ear receptor cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
ATP8B1, GABRA5, NAGLU |
GO:0060122 | BP | inner ear receptor stereocilium organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of inner ear receptor cells. |
SDC4, HES1, TRIP11, CTHRC1, IFT27, MKS1 |
GO:0060123 | BP | regulation of growth hormone secretion | Any process that modulates the frequency, rate or extent of the regulated release of growth hormone from a cell. |
CHD7 |
GO:0060124 | BP | positive regulation of growth hormone secretion | Any process that increases the frequency, rate or extent of the regulated release of growth hormone from a cell. |
GHRH, DRD2, ARHGEF7, KISS1, GHRL |
GO:0060125 | BP | negative regulation of growth hormone secretion | Any process that decreases or stops the frequency, rate or extent of the regulated release of growth hormone from a cell. |
PTPN11 |
GO:0060126 | BP | somatotropin secreting cell differentiation | The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a somatotropin secreting cell. A somatotropin secreting cell is an acidophilic cell of the anterior pituitary that produces growth hormone, somatotropin. |
PITX2 |
GO:0060127 | BP | prolactin secreting cell differentiation | The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a prolactin secreting cell. A prolactin secreting cell is an acidophilic cell of the anterior pituitary that produces prolactin. |
PITX2 |
GO:0060128 | BP | corticotropin hormone secreting cell differentiation | The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a corticotropic hormone secreting cell. An corticotropic hormone secreting cell is a basophil cell of the anterior pituitary that produces corticotropin. |
BMP2 |
GO:0060129 | BP | thyroid-stimulating hormone-secreting cell differentiation | The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a thyroid-stimulating hormone-secreting cell. A thyroid-stimulating hormone-secreting cell is a basophil cell of the anterior pituitary that produces thyroid-stimulating hormone, thyrotrophin. |
BMP2 |
GO:0060134 | BP | prepulse inhibition | The process in which a startle magnitude is reduced when the startling stimulus is preceded by a low-intensity prepulse. |
DRD2, CTNNA2, PTEN, NRXN1 |
GO:0060135 | BP | maternal process involved in female pregnancy | A reproductive process occurring in the mother that allows an embryo or fetus to develop within it. |
AGRP, ANGPT2, CCL2, AKR1B1, PAM, CNR1, ITGA3, UBE2A, ADCY7, PPAT, DSG2, APOL2 |
GO:0060136 | BP | embryonic process involved in female pregnancy | A reproductive process occurring in the embryo or fetus that allows the embryo or fetus to develop within the mother. |
ACSL4, JUNB, HSF1, SP3 |
GO:0060137 | BP | maternal process involved in parturition | A reproductive process occurring in the mother that results in birth. |
CYP1A1, EDN1, CCL2, OXTR |
GO:0060139 | BP | positive regulation of apoptotic process by virus | Any viral process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
BCL2L11, BAD |
GO:0060143 | BP | positive regulation of syncytium formation by plasma membrane fusion | Any process that increases the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells. |
CAMK1 |
GO:0060154 | BP | cellular process regulating host cell cycle in response to virus | Any cellular process that modulates the rate or extent of progression through the cell cycle in response to a virus. |
BCL2L11, BAD |
GO:0060155 | BP | platelet dense granule organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a platelet dense granule. A platelet dense granule is an electron-dense granule occurring in blood platelets that stores and secretes adenosine nucleotides and serotonin. They contain a highly condensed core consisting of serotonin, histamine, calcium, magnesium, ATP, ADP, pyrophosphate and membrane lysosomal proteins. |
ABCA1, F2R, BLOC1S1, BLOC1S3 |
GO:0060156 | BP | milk ejection | An automatic response to suckling, beginning with a nerve impulse from a receptor in the mammary gland and ending with the ejection of milk from the gland. Signaling never reaches a level of consciousness. |
GJA1 |
GO:0060157 | BP | urinary bladder development | The process whose specific outcome is the progression of the urinary bladder over time, from its formation to the mature structure. The urinary bladder is an elastic, muscular sac situated in the anterior part of the pelvic cavity in which urine collects before excretion. |
RBP4, WNT5A |
GO:0060158 | BP | phospholipase C-activating dopamine receptor signaling pathway | The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent release of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
DRD2, GNA11, GNAQ |
GO:0060160 | BP | negative regulation of dopamine receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of dopamine receptor protein signaling pathway activity. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. |
DRD2 |
GO:0060161 | BP | positive regulation of dopamine receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of the dopamine receptor protein signaling pathway. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. |
CAV2, VPS35 |
GO:0060163 | BP | subpallium neuron fate commitment | The process in which in the subpallium, the developmental fate of a cell becomes restricted such that it will develop into a neuron. The subpallium is the base region of the telencephalon. |
ASCL1 |
GO:0060164 | BP | regulation of timing of neuron differentiation | The process controlling the activation and/or rate at which a relatively unspecialized cell acquires features of a neuron. |
HES1 |
GO:0060165 | BP | regulation of timing of subpallium neuron differentiation | The process controlling the timing and/or rate at which a relatively unspecialized cell in the subpallium acquires features of a neuron. The subpallium is the base region of the telencephalon. |
ASCL1 |
GO:0060166 | BP | olfactory pit development | The biological process whose specific outcome is the progression of the olfactory pit from an initial condition to its mature state. This process begins with the formation of the olfactory pit, which is an indentation of the olfactory placode, and ends when the pits hollows out to form the nasopharynx. |
ALDH1A3, ASCL1, DLX5 |
GO:0060168 | BP | positive regulation of adenosine receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of the adenosine receptor signaling pathway. The adenosine receptor pathway is the series of molecular signals generated as a consequence of an adenosine receptor binding to one of its physiological ligands. |
ACPP |
GO:0060169 | BP | negative regulation of adenosine receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of the adenosine receptor signaling pathway. The adenosine receptor pathway is the series of molecular signals generated as a consequence of an adenosine receptor binding to one of its physiological ligands. |
ADA |
GO:0060170 | CC | ciliary membrane | The portion of the plasma membrane surrounding a cilium. |
CASK, GPI, DRD2, SCNN1A, EPS15, EVC, PKD1, PKD2, PTCH1, SEPT2, TCTN3, BBS7, BBS1, TTC8, TCTN2, HHIP, BBS2 |
GO:0060171 | CC | stereocilium membrane | The portion of the plasma membrane surrounding a stereocilium. |
MYO1C, FAM65B |
GO:0060173 | BP | limb development | The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin. |
GREM1, PAM, NR2F2, COMP, BMPR2, BBS7, LNP, RC3H2, IFT122, ZAK, CHD7, INTU |
GO:0060174 | BP | limb bud formation | The process pertaining to the initial formation of a limb bud from unspecified parts. This process begins with the formation of a local condensation of mesenchyme cells within the prospective limb field, and ends when a limb bud is recognizable. |
PLXNA2, FGFR2, SOX9, WNT3, SOX4, SEMA3C |
GO:0060175 | MF | brain-derived neurotrophic factor-activated receptor activity | Combining with a brain-derived neurotrophic factor and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
NTRK2 |
GO:0060177 | BP | regulation of angiotensin metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving angiotensin. |
ACE |
GO:0060178 | BP | regulation of exocyst localization | Any process that modulates the localization of exocysts. An exocyst is a protein complex peripherally associated with the plasma membrane that determines where vesicles dock and fuse. |
RALB |
GO:0060179 | BP | male mating behavior | The specific behavior of a male organism that is associated with reproduction. |
PTEN, NCOA1 |
GO:0060192 | BP | negative regulation of lipase activity | Any process that decreases the frequency, rate or extent of lipase activity, the hydrolysis of a lipid or phospholipid. |
APOA1, APOA2, PLIN5 |
GO:0060193 | BP | positive regulation of lipase activity | Any process that increases the frequency, rate or extent of lipase activity, the hydrolysis of a lipid or phospholipid. |
RHOA, PLIN5 |
GO:0060197 | BP | cloacal septation | The separation of the single opening of the digestive, urinary, and reproductive tracts, the cloaca, into multiple isolated openings during development. |
BMP4 |
GO:0060201 | CC | clathrin-sculpted acetylcholine transport vesicle membrane | The lipid bilayer surrounding a clathrin-sculpted acetylcholine transport vesicle. |
SYT1 |
GO:0060203 | CC | clathrin-sculpted glutamate transport vesicle membrane | The lipid bilayer surrounding a clathrin-sculpted glutamate transport vesicle. |
SYT1, VAMP2 |
GO:0060205 | CC | cytoplasmic membrane-bounded vesicle lumen | The volume enclosed by the membrane of a cytoplasmic membrane-bounded vesicle. |
ADA |
GO:0060213 | BP | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | Any process that increases the frequency, rate or extent of poly(A) tail shortening of a nuclear-transcribed mRNA. Poly(A) tail shortening is the decrease in length of the poly(A) tail of an mRNA from full length to an oligo(A) length. |
CNOT1, ZFP36, POLR2G, BTG2, CPEB3, TNRC6C, CNOT7, AGO2, TNRC6B |
GO:0060214 | BP | endocardium formation | Formation of the endocardium of the heart. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers. |
PROX1, SOX17 |
GO:0060215 | BP | primitive hemopoiesis | A first transient wave of blood cell production that, in vertebrates, gives rise to erythrocytes (red blood cells) and myeloid cells. |
STK4 |
GO:0060216 | BP | definitive hemopoiesis | A second wave of blood cell production that, in vertebrates, generates long-term hemopoietic stem cells that continously provide erythroid, myeloid and lymphoid lineages throughout adulthood. |
MEIS1, TAL1, ZFP36L2, SP3, TEK, TGFBR3, MFAP5, CBFB |